In this week’s video, Dr. Brian G.M. Durie explains which criteria and tests determine if a patient’s myeloma is smoldering or active.

BOTTOM LINE:
Only treat myeloma if test results are absolutely clear and show active disease.

Have a question? Submit it to [email protected]

IMF Chairman and Co-Founder Brian G.M. Durie, MD welcomes your questions about the latest myeloma treatments, research, controversies and quality of life issues. If you have a question you think might be of interest to the myeloma community, please send to [email protected].

For questions of a specific personal nature, please call the IMF InfoLine coordinators at 800.452.2873 or email them at [email protected]

Previous Post
Black Swan researchers identify good-risk and poor-risk MRD patients, China’s ‘disruptive’ biotech, and reasons to eat ‘real food’
Next Post
New myeloma research project follows in the footsteps of iStopMM to study myeloma precursors

Give Where Most Needed

We use cookies on our website to support technical features that enhance your user experience.

We also use analytics & advertising services. To opt-out click for more information.